Coatue
NVAX · Medicine & biotech

Novavax

Develops vaccines, including a COVID-19 shot now sold by Sanofi.
No change
Coatue owns 3.8 million shares of Novavax, worth about $36 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
3,836,986
Jun 30
3,836,986

The numbers

Shares they own
3,836,986
Value on Jun 30, 2026
$36,144,408
about $36 million
Share of their money
0.1%
less than $1 of every $100 · 42nd of 63
Price per share on Jun 30
$9.42
Kind
Shares
Also owned by
No other fund we follow
More about Novavax
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works